How to price the IP rights underpinning disruptive biotech innovation
Analysts must look beyond traditional valuation methodologies to an alternative real options framework if they are to get the most bang for their buck
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.